Elevation Oncology Inc (ELEV) Peer Comparison

$0.37

$0.00 (0.00%)

As on 01-Aug-2025 09:30EDT

Market cap

$22 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0.5

Div. Yield

0 %

Edit

	Elevation Oncology Inc (ELEV)	Sage Therapeutic (SAGE)
Market cap ($ Mln)	22	545
Revenue ($ Mln)	0	70
Net Profit ($ Mln)	-47.99	-301.20
Net Margin (%)	-126,286.84	-427.77
RoE (%)	-82.68	-72.24
Price to Earnings	--	--
Price-To-Book	0.46	1.48

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	Elevation Oncology Inc (ELEV)	Sage Therapeutic (SAGE)
Operating Revenue	0.04	70.41
Cost of Revenue	0.03	7.37
Gross Profit	-0.02	31.80
Operating Expenses	45.67	387.86
Operating Profit (EBIT)	-49.05	-324.82
Other Income	0.00	0.00
Profit before Tax	-47.95	-301.20
Provision for Tax	0.04	0.00
Profit after Tax (Net Income)	-47.99	-301.20
Minority Interest	0.00	0.00
Consolidated Profit	0.00	0.00

Liabilities ($ Mln)

	Elevation Oncology Inc (ELEV)	Sage Therapeutic (SAGE)
Shareholder's Funds	46.73	368.74
Minority Interest	0.00	0.00
Non-Current Liabilities	31.25	9.54
Current Liabilities	4.24	44.64
Total Liabilities	95.63	547.22

Assets ($ Mln)

	Elevation Oncology Inc (ELEV)	Sage Therapeutic (SAGE)
Non-Current Assets	0.03	13.84
Current Assets	82.19	409.09
Total Assets	95.63	547.22
Total Debt*	31.25	11.42
Net Current Assets	77.96	364.44

Cashflow ($ Mln)

	Elevation Oncology Inc (ELEV)	Sage Therapeutic (SAGE)
Cash From Operating Activities	-36.36	-267.19
Cash Flow from Investing Activities	-8.37	266.68
Cash from Financing Activities	44.94	10.66
Net Cash Inflow / Outflow	--	--

Ratios

Profitability Ratios

	Elevation Oncology Inc (ELEV)	Sage Therapeutic (SAGE)
ROCE (%)	-50.52	-62.52
ROE (%)	-82.68	-72.24
ROA (%)	-48.53	-48.83
EBIT Margin (%)	-126,005.26	-431.14
Net Margin (%)	-126,286.84	-427.77
Cash Profit Margin (%)	-6.65	0.00

Growth Ratios

	Elevation Oncology Inc (ELEV)	Sage Therapeutic (SAGE)
Revenue Growth (%)	-34.48	-27.59
EBIT Growth (%)	-24.15	32.47
Net Profit Growth (%)	-21.95	32.42
EPS Growth (%)	21.16	33.83
Book Value Growth (%)	-50.65	-43.23

Valuation Ratios

	Elevation Oncology Inc (ELEV)	Sage Therapeutic (SAGE)
Price / Earnings	-0.75	-0.82
Price / Book Value	0.55	0.71
Dividend Yield (%)	--	--
EV/EBITDA	0.64	0.40
Market Cap ($ Cr)	--	--

Solvency Ratios

	Elevation Oncology Inc (ELEV)	Sage Therapeutic (SAGE)
Debt to Equity	0.67	0.00
Short term debt to equity ratio	0.00	0.01
Current Ratio	19.40	9.16
Quick Ratio	19.40	9.16
Interest Coverage	-11.39	--

Operating Efficiency Ratios

	Elevation Oncology Inc (ELEV)	Sage Therapeutic (SAGE)
Debtors to sales (%)	0.00	37.74
Asset Turnover	0.00	0.11
Receivable days	--	408.01
Inventory Days	--	58.01
Payable days	8,111.59	445.10
Cash Conversion Cycle	--	20.93

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly